Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system

Viral Immunology

Volumn 19, Issue 4, 2006, Pages 741-746

  Carr, Daniel J J ^a   Campbell, Iain L ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLIAL FIBRILLARY ACIDIC PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; BRAIN STEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE CONTROL; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; INOCULATION; IRIS; KERATITIS; MALE; MOUSE; NERVOUS SYSTEM; NONHUMAN; OUTCOME ASSESSMENT; PROMOTER REGION; TRANSGENE; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIRUS LOAD; WILD TYPE;

HUMAN HERPESVIRUS 1; MUS; MUS MUSCULUS;

ANIMALS; BRAIN STEM; CERCOPITHECUS AETHIOPS; CHEMOKINES; CORNEA; FEMALE; HERPESVIRUS 1, HUMAN; INTERFERON-ALPHA; IRIS; KERATITIS, HERPETIC; MALE; MICE; MICE, TRANSGENIC; NERVOUS SYSTEM; TRIGEMINAL GANGLION; VERO CELLS;

EID: 33846108848     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.741     Document Type: Article

References (28)

1. Akwa Y, Hassett DE, Eloranta M-L, Sandberg K, Masliah E, Powell H, Whitton JL, Bloom FE, and Campbell IL: Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 1998;161:5016.
2. Austin BA, James C, Silverman RH, and Carr DJJ: Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-/3 during acute ocular herpes simplex virus type 1 infection. J Immunol 2006;175:1100.
3. Biswas PS, Banerjee K, Kim B, and Rouse BT: Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: Possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol 2004;172:3736.
4. Carr DJJ, Chodosh J, Ash J, and Lane TE: Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 2003;77:10037.
5. 1 protects mice from acute ocular herpes simplex virus type 1 infection. J Immunol 1998;161:4859.
6. Cook ML, and Stevens JG: Pathogenesis of herpetic neuritis and ganglionitis in mice: Evidence for intra-axonal transport infection. Infect Immun 1973;7:272.
7. Hacker HR, Vabulas M, Takeuchi O, Hoshino K, Akira S, and Wagner H: Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 2000;192:595.
8. Halford WP, Gebhardt BM, and Carr DJJ: Persistent cytokine expression in the trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 1996;157:3542.
9. Halford WP, Gebhardt BM, and Carr DJJ: Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology 1997;238:53.
10. Halford WP, Weisend C, Grace J, Soboleski M, Carr DJJ, Balliet JW, Imai Y, Margolis TP, and Gebhardt BM: ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: Implications for the regulation of viral latency. Virol J 2006;3:44.
11. Hamrah P, Huq SO, Liu Y, Zhang Q, and Dana MR: Corneal immunity is mediated by heterogenous population of antigen-presenting cells. J Leukoc Biol 2003;74:172.
12. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709.
13. Kumaraguru, U, David I, and Rouse BT: Chemokine and ocular pathology caused by corneal infection with herpes simplex virus. J Neurovirol 1999;5:42.
14. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, and Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004;101:1315.
15. Leib DA, Machalek MA, Williams BRG, Silverman RH, and Virgin HW: Specific phenotypic restoration of an attenuated virus, by knockout of a host resistance gene. Proc Natl Acad Sci USA 2000;97:6097.
16. Lin R, Noyce RS, Collins SE, Everett RD, and Mossman KL: The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004;78:1675.
17. Lundberg P, Welander P, Han X, and Cantin E: Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 2003;77:11158.
18. Milone MC, and Fitzgerald-Bocarsly P: The mannose receptor mediates induction of IFN-α in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J Immunol 1998;161:2391.
19. Mitchell WJ, Gressens P, Martin JR, and DeSanto R: Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J Gen Virol 1994;75:1201.
20. + T lymphocytes. J Immunol 2000;164:6435.
21. Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, and Johnson DC: Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci USA 2005;102:11462.
22. Shimeld C, Whiteland JL, Nicholls SM, Grinfeld E, Easty DL, Gao H, and Hill TJ: Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol 1995;61:7.
23. Streilein JW, Dana MR, and Ksander BR: Immunity causing blindness: Five different paths to herpes stromal keratitis. Immunol Today 1997;18:443.
24. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, and Lausch RN: Absence of macrophage inflammatory protein-1a prevents the development of blinding herpes stromal keratitis. J Virol 1998;72:3705.
25. Wuest T, Austin BA, Uematsu S, Thapa M, Akira S, and Carr DJJ: Intact TLR 9 and type I Interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J Neuroimmunol 2006;179:46.
26. Yokota S-i, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, and Fujii N: Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 2004;78:6282.
27. Zheng M, Deshpande S, Lee S, Ferrara N, and Rouse BT: Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 2001;75:9828.
28. Zheng M, Klinman DM, Gierynska M, and Rouse BT: DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci USA 2002;99:8944.